# Autonomous status

This is the single writable control document autonomous builders may routinely
update. It records durable project facts only. Transient publication state -
open pull requests, draft or review status, working branch names, head SHAs -
belongs in pull-request metadata and must never be recorded here. Frozen
decisions live in `validation/v1.1-design-record.md`,
`validation/v1.1-requirements.md`, and `validation/v1.1-test-intent.md`;
substantive changes require Austin's explicit approval.

## Current state

| Field | Value |
|---|---|
| Project phase | `V1_1_COMPLETE` - controlled error-queue recovery delivered, validated, and finalized |
| Active or approved implementation task | None |
| Autonomous Routine | `DISABLED` |
| Canonical audit record | `AUDIT_FINDINGS.md` (twelve findings; none `CLOSED`) |
| Future enhancements | Require a new bounded authorization from Austin before any work begins |

## v1.1 completion facts

- CytoBridge v1.1 controlled recovery is complete. The recovery workstream
  delivered the synthetic corpus (P2-001), the recovery schema (P3-001),
  structured failure classification (P3-002), the controlled recovery service
  (P3-003), the validation/UAT/portfolio closeout (P3-004), and the manual
  recovery UAT execution (P3-005).
- All 164 automated tests pass (`python -m pytest -q`, eight suites).
- All five demonstration scenarios pass (`python -m src.demo_run`, exit 0).
- UAT-011 through UAT-018 were manually executed successfully on 2026-07-25,
  including both UAT-015 subcases (UAT-015A and UAT-015B), and were confirmed
  by an independent replay in fresh synthetic state. The durable evidence is
  [`validation/v1.1-recovery-uat-execution-report.md`](validation/v1.1-recovery-uat-execution-report.md).
- UAT-001 through UAT-010 remain defined but have not been manually executed.
  The automated suite covers the same behavior; no manual pass is claimed for
  them.
- UAT-004 passed an AI-executed functional replay on 2026-09-04, including
  finalized export, complete presented-form preservation, and non-finalized
  rejection. The [synthetic evidence](validation/uat004-ai-functional-replay.json)
  and [replay helper](scripts/replay_uat004.py) preserve this narrower result;
  human acceptance and Austin's independent mastery remain unestablished.

## Accepted task history

| Task | Accepted outcome |
|---|---|
| P2-001 - Synthetic recovery corpus | Merged via PR #13 |
| P3-001 - Recovery data model and schema | Merged via PR #15 |
| P3-002 - Structured failure classification | Merged via PR #17 |
| P3-003 - Controlled recovery service core | Merged via PR #19 |
| P3-004 - Validation, UAT, and portfolio closeout | Merged via PR #21 |
| P3-005 - Recovery UAT evidence pilot | Executed 2026-07-25; durable evidence in the [execution report](validation/v1.1-recovery-uat-execution-report.md) |

## Governance

- `AUDIT_FINDINGS.md` remains the canonical audit record, including the v1.1
  finalization findings AF-2026-010 through AF-2026-012.
- The recurring Autonomous Routine is `DISABLED` and may be enabled only by
  Austin's explicit, separate authorization.
- The v1.1 finalization is complete in this document as written: there will be
  no post-merge status closeout, correction, or reconciliation change for it.
- All future agent work must follow the mandatory progress and meta-analysis
  checkpoint, publication preflight, and loop-detection stop triggers in
  [`AGENTS.md`](AGENTS.md) and the Audit Master Protocol in
  [`AUDIT_FINDINGS.md`](AUDIT_FINDINGS.md).

## Next permitted action

None. No implementation task is active or approved. Any future enhancement
(for example, the ISCN parser seam) starts with a new bounded authorization
from Austin: one task per branch and pull request, with one genuinely
independent review, and no status-only follow-up work.
